Bullous pemphigoid or probable Monkeypox is triggered by mRNA Covid-19 vaxx
Published by the National Library of Medicine, Maryland, US, October 2021
Bullous pemphigoid (BP) is an autoimmune skin disease characterized by the appearance of tense blisters over an erythematous base and the existence of circulating G immunoglobulins (IgGs) against hemidesmosome antigens BP180 and BP230.1 In this paper we present the case of a woman who developed BP after receiving the first dose of COMIRNATY (messenger ribonucleic acid [RNAm] Pfizer-BioNTech vaccine) and a subsequent reactivation after receiving the second one.
The case corresponds to a 78-year-old woman with diabetes mellitus, treated with insulin, and Alzheimer’s disease (global deterioration scale [GDS] score of 4), treated with memantine. She consulted the Dermatology Department due to a 1.5-month history of skin rash, reporting that the lesions had appeared three days after she received the COMIRNATY vaccine. Her symptoms stabilized within two weeks with the aid of high-potency topical corticosteroids. However, 21 days later, she experienced a significant reactivation after receiving the second dose of the vaccine (Fig. 1 ). A physical examination revealed tense blisters over an erythematous base on her face, trunk, and limbs. No lesions were detected on any of her mucous surfaces. A skin biopsy confirmed the diagnosis of BP, with both direct and indirect positive serum immunofluorescence. The remaining laboratory analyses yielded normal results, except for mild eosinophilia. We informed the Pharmacovigilance System and started treatment with prednisone 40 mg every 24 h, achieving a good clinical response.
The two BP antigens are found in the hemidesmosome, a cell adhesion complex that anchors the epithelium to the basement membrane. It has been proposed that IgG bound to these antigens activates the complement by inducing inflation and interrupting this bond.2 Genetic predisposition and certain triggering factors are involved in its etiopathogenesis. The association between BP and basement membrane alterations, such as traumas or burns; certain drugs, such as oral antidiabetics; or neurological diseases, such as Parkinson’s disease or dementia, is well known.2,
3 The latter association is partly explained by the autoimmune cross-reaction that occurs between the BP230 protein isoforms present in both the skin and the central nervous system.2 In relation to vaccines, cases of BP have been reported following the administration of vials against tetanus, diphtheria, pertussis, polio, rabies, hepatitis B, rotavirus, pneumococcus, or influenza.1, 2, 3, 4, 5 The latency period ranges between one day (or earlier in the case of the pediatric population)1 and one month following the vaccination.2, 4, 5 The mechanism by which the vaccine induces BP is not well understood, and it is unlikely that a vaccine itself would explain the association, as there are no similarities between the vaccine structure and the basement membrane antigens.2 One hypothesis that has previously been proposed is that the vaccination may trigger a greater autoimmune response in patients with a significant immunological predisposition,2, 4 such as the case of our patient with Alzheimer’s disease, as the vaccine would activate B-cell immunity and, therefore, the production of antibodies,4 which is the main mechanism by which the lesions of this disease are generated.
In our patient, BP developed within three days of the administration of the first dose of the COMIRNATY vaccine against the 2019 coronavirus disease (COVID-19). The appearance of these lesions was followed by a period of clinical stabilization during the second week after the vaccination. This was followed by a significant reactivation of the lesions 21 days later, after she received the second dose of the vaccine. The timeline with respect to the administration of the first dose and the reactivation after the administration of the second one supports the hypothesis of a possible relationship between the COMIRNATY vaccine administered and the appearance of BP in our patient, with a score of 8 (possible causal reaction) in the Naranjo Adverse Drug Reaction Probability Scale.#
Pfizer executive forced to admit natural immunity works well
By TONY MOBILIFONITIS
TWO major studies in Israel and the UK have forced Pfizer executive Scott Gottlieb MD to admit that natural immunity acquired against Covid 19 (SARS-Cov-2) works.
But the mouthpiece of the corrupt drug giant that has paid out billions in fines for criminal fraud and is again under legal scrutiny, won’t concede what the studies really find – that natural immunity is far superior than the artificial immunity from vaccines.
Gottlieb’s mates over at the US Food and Drug Administration (FDA), where he came from before joining the Pfizer board, claim they need more than half a century to process and release papers around its approval of Pfizer’s “Comirnaty” mRNA vaccine.
The FDA is being sued by to fully release redacted versions of all documents related to the vaccine approval process, but claims the process will take 55 to 75 years – if you can believe that.
In August, the group of more than 30 scientists, medical professionals, international public health professionals and journalists called Public Health and Medical Professionals for Transparency (PHPMT), filed a Freedom of Information Act (FOIA) request with the FDA to obtain the data.
The group includes Yale School of Public Health epidemiologist Harvey Risch, and others from institutions such as Harvard, Brown and UCLA. Prof. Risch advocated use of hydroxychloroquine early in the pandemic, but was shouted down by a pack of anti-Trump academic cowards at the time.
But Gottlieb, who once claimed natural immunity wasn’t good enough against Covid, is now changing his tune. He told CNBC “natural immunity confers durable protection” and suggested policymakers “start assimilating that into our policy discussion”. Really?
Pfizer, with the help of the Trump administration and Anthony Fauci, gained emergency use authorization (EUA) approval of its BioNTech mRNA vaccine in the so-called Operation Warp Speed. But that may have been a cover for the mRNA vaccines, which according to investigations by Dr David Martin, were under development well before the so-called Covid-19 virus “broke out” in China.
Early in August, the FDA approved a biologics license application for Pfizer’s “Comirnaty” vaccine. As indicated by Robert Kennedy Jnr’s The Defender website, Pfizer and the FDA pulled a sleight of hand trick – which would be nothing new for the corrupt partnership.
First, the FDA said Pfizer had “insufficient stocks” of the newly licensed Comirnaty, but “a significant amount” of Pfizer-BioNTech vaccine produced under emergency use, so the BioNTech vaccine should remain unlicensed but could be used “interchangeably” with Comirnaty. Other reports were emerging that BioNTech would never get normal FDA approval without the emergency use status.
The FDA also said the new Comirnaty vaccine and existing BioNTech were “legally distinct”, but that difference “did not impact safety or effectiveness”. So in effect they simply created a new brand name for its dangerous, mass-produced BioNTech shots that were bought by countries like Australia and New Zealand for billions of dollars.
On July 25th Scott Morrison announced Australia had secured an additional 85 million doses of Pfizer-BioNTech vaccine, bringing Australia’s total Pfizer doses to 125 million.
Morrison said through the government’s “continued engagement with Pfizer-BioNTech” it secured 60 million doses in 2022, and 25 million doses in 2023. Delivery was to begin in the first quarter of 2022 and “enable booster coverage throughout the year”.
So despite Pfizer’s talk around its “new” Comirnaty shots, Australia ended up getting dumped with 125 million doses of the experimental mRNA shots that could only get safety approval with emergency use authorisation.
Earlier, in June, the original developer of mRNA technology, Dr Richard Malone, warned the FDA the Pfizer and Moderna mRNA vaccines were not working as they were supposed to. He described them as “very dangerous” on Brett Weinstein’s Dark Horse podcast. He produced data and scientific papers to support his warnings but was brushed off despite his high standing. Media of course, went on the attack to “fact check” him.
Dr Malone told Laura Ingraham on Fox he took two shots of Moderna’s mRNA vaccine and said he suffered narcolepsy, restless leg syndrome and ongoing dangerously high blood pressure. Malone was under attack from all directions.
“To those that think I am posting due to my political bias. News 4 you – it is because of my upbringing. I was taught to not lie. And I got fed up with the lies, misrepresentations, obfuscation, censorship, and imbicilic fact checking. I actually donated to the Biden campaign,” Malone posted on Twitter.
But the smoke and mirror operations by Pfizer, the FDA and the CDC were not working with increasing numbers of people in the medical and scientific community.
In the latest federal court filing the FDA stated it could process the 329,000 pages of documents at a rate of only 500 pages per month because it needs the time to redact exempt material. At that rate, the documentation will not be fully released until 2076.
Then in a legal brief filed on Dec. 7th, the FDA said 59,000 additional pages of documents, not included in the agency’s earlier filings, need to be processed. The agency did not offer an explanation for why those documents initially were overlooked.
The agency said it could release an initial batch of approximately 12,000 pages by the end of January and past that date, could process and disclose “only 500 pages of documents per month”. This sounds like a highly organised corporate snow job. Cairns News will be watching. Readers should also monitor Robert F. Kennedy Jnr’s The Defender website on vaccine-related issues.